R R Packer

500 total citations
22 papers, 418 citations indexed

About

R R Packer is a scholar working on Pharmacology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, R R Packer has authored 22 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmacology, 13 papers in Molecular Medicine and 8 papers in Infectious Diseases. Recurrent topics in R R Packer's work include Antibiotics Pharmacokinetics and Efficacy (18 papers), Antibiotic Resistance in Bacteria (13 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). R R Packer is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (18 papers), Antibiotic Resistance in Bacteria (13 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). R R Packer collaborates with scholars based in United States and Taiwan. R R Packer's co-authors include A L Barry, Ronald N. Jones, Peter Fuchs, Michael A. Pfaller, Arthur L. Barry, C Thornsberry, C N Baker, Robert E. Badal, Clyde Thornsberry and Jennifer L. Cotton and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and American Journal of Clinical Pathology.

In The Last Decade

R R Packer

21 papers receiving 345 citations

Peers

R R Packer
A Thabaut France
H. Drugeon France
D. Hoban Canada
P. Hohl Switzerland
M Meyran France
B J McGrath United States
Linda M. Kelly United States
D L Rotella United States
Khalid H. Ibrahim United States
A Thabaut France
R R Packer
Citations per year, relative to R R Packer R R Packer (= 1×) peers A Thabaut

Countries citing papers authored by R R Packer

Since Specialization
Citations

This map shows the geographic impact of R R Packer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R R Packer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R R Packer more than expected).

Fields of papers citing papers by R R Packer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R R Packer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R R Packer. The network helps show where R R Packer may publish in the future.

Co-authorship network of co-authors of R R Packer

This figure shows the co-authorship network connecting the top 25 collaborators of R R Packer. A scholar is included among the top collaborators of R R Packer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R R Packer. R R Packer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barry, A L, Michael A. Pfaller, Peter Fuchs, & R R Packer. (1994). In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993. Antimicrobial Agents and Chemotherapy. 38(10). 2419–2425. 150 indexed citations
2.
Barry, A L & R R Packer. (1992). Performance of Haemophilus Test Media prepared with 12 different lots of Mueller-Hinton agar from four manufacturers. Journal of Clinical Microbiology. 30(5). 1145–1147. 9 indexed citations
3.
Jones, Ronald N., et al.. (1989). The prevalence of staphylococcal resistance to penicillinase-resistant penicillins. Diagnostic Microbiology and Infectious Disease. 12(5). 385–394. 40 indexed citations
4.
Barry, Arthur L., et al.. (1987). Bactericidal activities of ten different fluoroquinolones against selected enterobacteriaceae. Diagnostic Microbiology and Infectious Disease. 6(1). 81–83. 4 indexed citations
5.
Barry, A L, Ronald N. Jones, & R R Packer. (1986). Antistaphylococcal activity of ceforanide and cefonicid in the presence of human serum. Antimicrobial Agents and Chemotherapy. 29(1). 147–149. 11 indexed citations
6.
Barry, A L, Jennifer L. Cotton, Ronald N. Jones, & R R Packer. (1986). Evaluation of a proprietary broth medium for microdilution susceptibility testing of nutritionally fastidious bacteria. Journal of Clinical Microbiology. 24(5). 701–704. 2 indexed citations
7.
Barry, A L & R R Packer. (1986). Roxithromycin bioassay procedures for human plasma, urine and milk specimens. European Journal of Clinical Microbiology & Infectious Diseases. 5(5). 536–540. 9 indexed citations
8.
Jones, Ronald N., Arthur L. Barry, Clyde Thornsberry, Peter Fuchs, & R R Packer. (1986). The Anti-Microbial Activity, Beta-Lactamase Stability, and Disk Diffusion Susceptibility Testing of Carumonam (RO 17-2301, AMA-1080), a New Monobactam. American Journal of Clinical Pathology. 86(5). 608–618. 7 indexed citations
9.
Barry, Arthur L., et al.. (1985). BMY28142, cefbuperazone (T-1982), and Sch 34343 antimicrobial activity against 94 anaerobes compared to seven other antimicrobial agents. Diagnostic Microbiology and Infectious Disease. 3(3). 263–268. 8 indexed citations
10.
Barry, A L, R R Packer, & Ronald N. Jones. (1985). Cefoperazone and cefoperazone-sulbactam susceptibility tests with anaerobic bacteria by the thioglycolate disk elution method. Journal of Clinical Microbiology. 22(5). 882–883. 3 indexed citations
11.
Barry, A L, et al.. (1985). Feasibility study of disk diffusion susceptibility tests with Mueller-Hinton broth solidified with Gelrite, an agar substitute. Journal of Clinical Microbiology. 21(3). 409–414. 4 indexed citations
12.
Jones, Ronald N. & R R Packer. (1984). Cefotaxime, cephalothin, and cephapirin: Antimicrobial activity and synergy studies of cephalosporins with significant in vivo desacetyl metabolite concentrations. Diagnostic Microbiology and Infectious Disease. 2(1). 65–68. 13 indexed citations
13.
Barry, A L, R R Packer, & Ronald N. Jones. (1984). Unpredictable interactions between cefotetan and penicillins or aminoglycosides. Diagnostic Microbiology and Infectious Disease. 2(4). 347–351. 2 indexed citations
14.
Barry, A L & R R Packer. (1984). Determination of susceptibility of anaerobic bacteria to cefotetan and cefoxitin by the thioglycolate disk elution method. Journal of Clinical Microbiology. 20(5). 912–916. 13 indexed citations
15.
Jones, Ronald N. & R R Packer. (1982). Antimicrobial activity of amikacin combinations against Enterobacteriaceae moderately susceptible to third-generation cephalosporins. Antimicrobial Agents and Chemotherapy. 22(6). 985–989. 28 indexed citations
16.
Thornsberry, Clyde, A L Barry, Ronald N. Jones, et al.. (1981). Antibacterial activity of fortimicin A compared with those of five other aminoglycosides, and factors affecting susceptibility tests. Antimicrobial Agents and Chemotherapy. 19(1). 122–129. 14 indexed citations
17.
Thornsberry, Clyde, A L Barry, Ronald N. Jones, et al.. (1980). Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin. Antimicrobial Agents and Chemotherapy. 18(2). 338–345. 13 indexed citations
18.
Jones, Ronald N., C Thornsberry, A L Barry, et al.. (1980). Compound A49759, the 3-O-demethyl derivative of fortimicin A: in vitro comparison with six other aminoglycoside antibiotics. Antimicrobial Agents and Chemotherapy. 18(5). 773–779. 13 indexed citations
19.
Jones, Ronald N., R R Packer, A L Barry, et al.. (1979). Piperacillin (T-1220), a new semisynthetic penicillin. II. In vitro antimicrobial activity and synergy comparison with carbenicillin and gentamicin.. The Journal of Antibiotics. 32(1). 29–35. 11 indexed citations
20.
Jones, Ronald N., et al.. (1978). Stability of antimicrobials in Schaedler's anaerobic and brain heart infusion broths stored at -20.DEG.C.. The Journal of Antibiotics. 31(3). 226–228. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026